The best indicator for J.B. Hunt (JBHT)
We backtested 20 indicators across daily, weekly and hourly charts on real J.B. Hunt (JBHT) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Money Flow Index
On the daily chart, this is the strongest risk-adjusted edge we found for J.B. Hunt (JBHT) over ~42.5 years — trailing buy-and-hold by 2.3% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Money Flow Index ✓ | Daily | 11.7% | 0.62 | -53.3% | 77.0% | 61 | -2.3% |
| 2 | WaveTrend (8/6/4) ✓ | Daily | 12.3% | 0.57 | -47.3% | 69.0% | 158 | -1.8% |
| 3 | Williams %R ✓ | Daily | 9.7% | 0.51 | -46.7% | 70.0% | 277 | -4.3% |
| 4 | Stochastic ✓ | Weekly | 9.2% | 0.51 | -48.3% | 79.2% | 48 | -4.6% |
| 5 | Williams %R ✓ | Weekly | 8.8% | 0.48 | -48.3% | 75.0% | 60 | -5.1% |
| 6 | WaveTrend (8/6/4) ✓ | Weekly | 8.9% | 0.48 | -60.8% | 86.5% | 37 | -4.9% |
| 7 | Holy Grail Confluence ✓ | Weekly | 7.0% | 0.55 | -24.8% | 100.0% | 13 | -6.9% |
| 8 | Stochastic ✓ | Daily | 8.4% | 0.46 | -47.3% | 70.8% | 216 | -5.6% |
| 9 | MACD ✓ | Weekly | 7.5% | 0.42 | -59.7% | 49.5% | 93 | -6.4% |
| 10 | RSI Trend (>50) ✓ | Weekly | 7.5% | 0.41 | -66.9% | 40.7% | 123 | -6.4% |
| 11 | CCI ✓ | Weekly | 6.8% | 0.41 | -50.0% | 82.1% | 39 | -7.0% |
| 12 | Donchian Midline ✓ | Weekly | 7.7% | 0.41 | -50.8% | 40.3% | 124 | -6.2% |
| 13 | EMA 20/50 Cross ✓ | Daily | 6.9% | 0.38 | -58.8% | 39.4% | 104 | -7.1% |
| 14 | Holy Grail Confluence ✓ | Daily | 5.4% | 0.35 | -65.2% | 72.6% | 62 | -8.6% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For J.B. Hunt (JBHT), Money Flow Index on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.